课题基金 / 基金详情

Allosteric modulators as novel probes of G-Protein coupled receptor function

Allosteric modulators as novel probes of G-Protein coupled receptor function
变构调节剂作为 G 蛋白偶联受体功能的新型探针
批准号:
DP0877497
负责人:
Prof Peter Scammells
金额:
$20.82万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-02 至 2011-12-31

项目摘要

项目成果

Prof Peter Scammells的其他基金

相似基金

相关文献

中文摘要
翻译
这项研究将为哺乳动物基因组中最大的蛋白质家族之一的功能提供新的机制理解,也是关于药物靶点的最重要的家族之一。因此,所获得的洞察力与药物发现直接相关。新型G蛋白偶联受体(GPCR)变构增强剂的发现不仅将带来潜在的新的治疗药物,而且可以显著增加其他专注于GPCR结构生物学的国家研究工作的价值。
英文摘要
This research will provide novel mechanistic understanding on the function of one of the largest protein families in the mammalian genome, and the most important family with respect to drug targets. The insights gained thus have direct relevance to drug discovery. The discovery of novel G protein-coupled receptor (GPCR) allosteric enhancers will not only lead to potentially new therapeutic agents, but can significantly value-add to other national research efforts focusing on GPCR structural biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical-biology approaches to pathway selective adenosine receptor ligands
  • 批准号:
    DP190101945
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $31.61万
  • 财政年份:
    2019
  • 负责人:
    Prof Peter Scammells
  • 依托单位:
Allosteric and Bitopic Ligands Acting at G Protein-Coupled Receptors
  • 批准号:
    DP160101970
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $46.82万
  • 财政年份:
    2016
  • 负责人:
    Prof Peter Scammells
  • 依托单位:
New methodology for the manufacture of opioid pharmaceuticals and the discovery of novel opiate receptor ligands
  • 批准号:
    LP110200377
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $15.04万
  • 财政年份:
    2012
  • 负责人:
    Prof Peter Scammells
  • 依托单位:
Understanding allosteric modulation and functional selectivity at G Protein-Coupled Receptors (GPCRs)
  • 批准号:
    DP110100687
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.56万
  • 财政年份:
    2012
  • 负责人:
    Prof Peter Scammells
  • 依托单位:
海外基金